-
Sector Analysis
Stone Management Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Stone Management Disposables Market Overview The stone management disposables market size was valued at $733.4 million in 2023. Factors such as increasing population and changing lifestyles will drive the market growth at a CAGR of more than 5% from 2023 to 2033. Nephrolithiasis is the process of formation of kidney stones in the kidney or at the lower end of the urinary tract. Urinary tract stones are known to occur more commonly in men than in women. The occurrence ratio...
-
Product Insights
NewIncontinence Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Incontinence devices are externally or internally worn devices intended to protect the skin from the involuntary loss of urine. GlobalData's Medical Devices sector report, “Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Incontinence Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Incontinence Devices report provides key information...
-
Product Insights
NewUreteroscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ureteroscopes Pipeline Market Report Overview Ureteroscope is an endoscope used for examining the upper urinary tract. A ureteroscope is inserted into the bladder and ureter and is used to diagnose and treat a variety of problems in the urinary tract. Physicians can use Ureteroscopes to remove kidney stones. The ureteroscopes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories...
-
Product Insights
NewUrinary Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A urinary catheter is a tube system to drain and collect urine from the bladder. These are used to manage urinary incontinence and urinary retention in both men and women. GlobalData's Medical Devices sector report, “Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Urinary Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Chondrosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Chondrosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Chondrosarcoma Drug Details: Toripalimab (Tuoyi, Loqtorzi) is a monoclonal antibody,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Soft Tissue Sarcoma Drug Details: Toripalimab (Tuoyi, Loqtorzi)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Melanoma Drug Details: Toripalimab (Tuoyi, Loqtorzi) is a monoclonal antibody,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Gastric Cancer Drug Details: Toripalimab (Tuoyi, Loqtorzi) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Hepatocellular Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Hepatocellular Carcinoma Drug Details: Toripalimab (Tuoyi, Loqtorzi) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Solid Tumor Drug Details: Toripalimab (Tuoyi, Loqtorzi) is a...